Clinical Trials
43
Active:0
Completed:28
Trial Phases
4 Phases
Phase 1:21
Phase 2:6
Phase 3:9
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (43 trials with phase data)• Click on a phase to view related trials
Phase 1
21 (48.8%)Phase 3
9 (20.9%)Phase 4
7 (16.3%)Phase 2
6 (14.0%)Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes
Phase 4
Not yet recruiting
- Conditions
- Ophthalmological Agent Toxicity
- Interventions
- Drug: Manzanilla Sophia®Drug: Meticel Ofteno® 0.5%
- First Posted Date
- 2025-03-05
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- Laboratorios Sophia S.A de C.V.
- Target Recruit Count
- 168
- Registration Number
- NCT06859476
Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children.
Phase 3
Recruiting
- Conditions
- MyopiaMyopia, Progressive
- Interventions
- Drug: Alleance®Drug: Placebo
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Laboratorios Sophia S.A de C.V.
- Target Recruit Count
- 123
- Registration Number
- NCT06389110
- Locations
- 🇲🇽
Innovación Y Desarrollo En Ciencias de La Salud S de Rl de Cv, Mexico City, Mexico
Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.
Phase 1
Not yet recruiting
- Conditions
- Dry Eye SyndromesDry EyeDry Eyes Chronic
- Interventions
- First Posted Date
- 2024-04-23
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Laboratorios Sophia S.A de C.V.
- Target Recruit Count
- 32
- Registration Number
- NCT06379685
Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®
Phase 1
Not yet recruiting
- Conditions
- Dry Eye DiseaseDry Eye SensationOcular Surface Disease
- Interventions
- Drug: Optive®
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Laboratorios Sophia S.A de C.V.
- Target Recruit Count
- 32
- Registration Number
- NCT06375343
Study of Non-inferiority Between Manzanilla Sophia® and Meticel Ofteno® 0.5% for Providing a Soothing Sensation to the Eyes.
Phase 4
Withdrawn
- Conditions
- Eye Strain of Both EyesEye Strain
- Interventions
- Drug: Manzanilla Sophia®Drug: Meticel Ofteno®
- First Posted Date
- 2024-04-18
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Laboratorios Sophia S.A de C.V.
- Target Recruit Count
- 100
- Registration Number
- NCT06373653
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
No news found